Literature DB >> 1580238

Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up.

N Krieger1, R A Hiatt.   

Abstract

The issue of risk of breast cancer subsequent to benign breast diseases (BBD) remains controversial. To determine whether this risk varies by histologic type of BBD, degree of atypia (as measured by the Black-Chabon method), age at BBD biopsy, or length of follow-up, the authors followed 2,731 women in the San Francisco Bay Area for an average of 16 years after their first occurrence of biopsy-proven BBD between 1948 and 1973. The cohort's age-adjusted rate of breast cancer was 1.8 times that of the general population (95% confidence interval (CI) 1.6-2.2). Among the different histologic types of BBD, rates were greatest for intraductal papilloma (rate ratio (RR) = 3.9, 95% CI 2.0-7.4) and adenosis (RR = 2.5, 95% CI 1.2-4.9). Rates were also significantly elevated for fibrocystic BBD (RR = 1.5, 95% CI 1.1-1.9). Risk increased directly with degree of atypia, rising from a rate ratio of 1.8 among women with Black-Chabon scores of 1 and 2 (95% CI 1.5-2.2) to 7.2 among women with a Black-Chabon score of 5 (95% CI 1.8-28.9). Among women with the higher-risk types of BBD, rate ratios increased with age at BBD biopsy and decreased with increasing length of cancer-free follow-up. These findings are interpreted in the light of possible biases affecting this and other studies and recent advances in knowledge regarding neoplastic lesions and breast cell kinetics.

Entities:  

Mesh:

Year:  1992        PMID: 1580238     DOI: 10.1093/oxfordjournals.aje.a116341

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  14 in total

1.  The long and short of chromosome 11 in breast cancer.

Authors:  I F Newsham
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

2. 

Authors:  G Schüler; F Gutzwiller
Journal:  Arch Gynecol Obstet       Date:  1995-12       Impact factor: 2.344

3.  Benign breast disease and subsequent breast cancer: English record linkage studies.

Authors:  M J Goldacre; J D Abisgold; D G R Yeates; M P Vessey
Journal:  J Public Health (Oxf)       Date:  2010-02-12       Impact factor: 2.341

4.  A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer.

Authors:  Geoffrey C Kabat; Joan G Jones; Neal Olson; Abdissa Negassa; Catherine Duggan; Mindy Ginsberg; Rita A Kandel; Andrew G Glass; Thomas E Rohan
Journal:  Cancer Causes Control       Date:  2010-01-19       Impact factor: 2.506

Review 5.  Evaluation and management of high risk and premalignant lesions of the breast.

Authors:  D L Page; R A Jensen
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

Review 6.  Anatomic indicators (histologic and cytologic) of increased breast cancer risk.

Authors:  D L Page; W D Dupont
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

7.  Detection of monoclonal microsatellite alterations in atypical breast hyperplasia.

Authors:  C L Rosenberg; A de las Morenas; K Huang; L A Cupples; D V Faller; P S Larson
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

8.  Risk factors for breast cancer from benign breast disease in a diverse population.

Authors:  Maria J Worsham; Usha Raju; Mei Lu; Alissa Kapke; Alyssa Botttrell; Jingfang Cheng; Varsha Shah; Adnan Savera; Sandra R Wolman
Journal:  Breast Cancer Res Treat       Date:  2008-10-04       Impact factor: 4.872

9.  Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses' Health Studies.

Authors:  Laura C Collins; Sarah A Aroner; James L Connolly; Graham A Colditz; Stuart J Schnitt; Rulla M Tamimi
Journal:  Cancer       Date:  2015-11-13       Impact factor: 6.860

10.  Clinical characteristics of breast cancers in African-American women with benign breast disease: a comparison to the surveillance, epidemiology, and end results program.

Authors:  Susanna D Mitro; Rouba Ali-Fehmi; Sudeshna Bandyopadhyay; Baraa Alosh; Bassam Albashiti; Derek C Radisky; Marlene H Frost; Amy C Degnim; Julie J Ruterbusch; Michele L Cote
Journal:  Breast J       Date:  2014-09-08       Impact factor: 2.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.